
Ravi Patel, MD, PhD, discusses expanding theranostics access, personalized dosing strategies, and translational research in radiation oncology.
A 50-year-old male is receiving capecitabine with concurrent radiation therapy for stage III rectal cancer. For the past 7 days, the patient has been taking ciprofloxacin for a urinary tract infection. He has a 1-week history of a tingling sensation in both the palms of his hands and soles of his feet, and a 3-day history of hand edema and erythema.
The diagnosis is:






